Geode Capital Management LLC Has $7.51 Million Holdings in SIGA Technologies, Inc. (NASDAQ:SIGA)

Geode Capital Management LLC lifted its position in shares of SIGA Technologies, Inc. (NASDAQ:SIGA) by 6.3% in the third quarter, HoldingsChannel.com reports. The fund owned 1,112,743 shares of the company’s stock after buying an additional 66,344 shares during the period. Geode Capital Management LLC’s holdings in SIGA Technologies were worth $7,512,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Larson Financial Group LLC acquired a new position in SIGA Technologies during the third quarter valued at approximately $30,000. DekaBank Deutsche Girozentrale acquired a new position in shares of SIGA Technologies during the 2nd quarter worth $40,000. EP Wealth Advisors LLC acquired a new position in shares of SIGA Technologies during the 3rd quarter worth $82,000. XTX Topco Ltd bought a new stake in shares of SIGA Technologies during the 3rd quarter worth $85,000. Finally, China Universal Asset Management Co. Ltd. boosted its stake in SIGA Technologies by 64.3% in the third quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock valued at $93,000 after buying an additional 5,372 shares in the last quarter. Institutional investors and hedge funds own 55.40% of the company’s stock.

SIGA Technologies Trading Up 3.8 %

Shares of NASDAQ SIGA opened at $6.24 on Friday. The company has a market cap of $445.57 million, a price-to-earnings ratio of 5.20 and a beta of 0.89. SIGA Technologies, Inc. has a 12 month low of $4.26 and a 12 month high of $12.83. The stock has a 50-day moving average price of $6.63 and a two-hundred day moving average price of $7.64.

SIGA Technologies (NASDAQ:SIGA) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter. The company had revenue of $10.01 million for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. On average, sell-side analysts predict that SIGA Technologies, Inc. will post 1.04 earnings per share for the current year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.